Medical disclaimer
Nothing on d2cpeptides.com is medical advice. This page explains what our education pages are, how to weigh the evidence they report, and when to talk to a licensed clinician instead.
Draft for legal review.
Last updated .
Not medical advice
Everything on d2cpeptides.com is general information. That includes product pages, education pages, guides, calculators, FAQ answers and the chat assistant. None of it is medical advice, a diagnosis or a treatment plan.
D2C Peptides is a store, not a medical practice. No one here can advise you about your own health, and reading this site does not make anyone our patient. Do not use anything on this site to decide whether to start, stop or change a medicine, a diet or any other treatment.
Our products are sold for research, not treatment
Every product page carries the label: For research use only. Not for human or veterinary use. These products are research materials. No page on this site tells anyone to use them, and nothing here offers them for use in people or for veterinary care. The research use policy sets out what that means for buyers.
Some research compounds share a name with the active ingredient of an approved medicine, such as semaglutide or tirzepatide. A research vial is still not that medicine. FDA has warned companies that sold research-labeled semaglutide, tirzepatide and retatrutide directly to consumers for human use.1 It urges consumers not to buy such products, because their quality is unknown and they may be harmful.1
If you are looking for treatment
Take any question about a symptom, a condition or a medicine to a licensed clinician. FDA says prescription drugs can be dispensed only with a prescription from a licensed practitioner.2 It tells consumers to get a prescription from their doctor, fill it at a state-licensed pharmacy, and buy medicines online only from state-licensed pharmacies.1 FDA also states that compounded drugs are not FDA approved, which means it does not review them for safety, effectiveness or quality before they are marketed.1
If you think you or someone else is having a medical emergency, call 911.
How to read our education pages
Our education pages summarize published sources and cite each health statement, so you can open the source and read it yourself. The type of evidence behind a statement matters as much as the finding:
- Label facts. For an approved medicine, uses, doses, warnings and side effects come from its FDA-approved label. The prescriber sets the dose for each patient.
- Human studies. A trial result describes the people in that trial: how many, for how long and at what dose. It may not apply to anyone else.
- Animal and cell studies. A result "in rats" or "in cell studies" shows what happened in that model. It does not show that the same effect, or the same safety, holds in people.
- Dosage pages. For a compound that is not an approved medicine, a dosage page lists only doses used in published studies, with the species, route and length of each study. It states that no human dose is established. These are records of research, not instructions.
- Side effect pages. They list what the label or the cited studies report, and may not include every effect a person could have.
How sources are chosen and pages are checked is explained in how we source and review our content.
Calculators and the chat assistant
Our calculators do arithmetic on the numbers you type in, such as the amount of peptide in a vial and the volume of diluent added. They never suggest an amount to use, and a result is not a dose.
The chat assistant answers by quoting our published pages and product data. It does not give doses or health advice for a person, and it points other questions to the contact page.
Errors and changes
Research and regulations change, and a page can fall behind them. Check the year of each cited source to see how current the evidence is. If you find a statement that is wrong or out of date, tell us through the contact page, naming the page and the sentence.
Sources
- FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. US Food and Drug Administration, 2026.
- Warning Letter: USApeptide.com, MARCS-CMS 696885 (February 26, 2025). US Food and Drug Administration, CDER, 2025.